The European Association of Urology renal cancer guidelines have been updated to recommend nivolumab and cabozantinib over the previous standard of care in patients who have failed one or more lines of VEGF targeted therapy.
European urology. 2015 Oct 24 [Epub ahead of print]
Thomas Powles, Michael Staehler, Börje Ljungberg, Karim Bensalah, Steven E Canfield, Saeed Dabestani, Rachel Giles, Fabian Hofmann, Milan Hora, Markus A Kuczyk, Thomas Lam, Lorenzo Marconi, Axel S Merseburger, Alessandro Volpe, Axel Bex
The Royal Free NHS Trust and Barts Cancer Institute, Queen Mary University of London, London, UK. Department of Urology, Ludwig-Maximilians University, Munich, Germany. , Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden. , Department of Urology, University of Rennes, Rennes, France. , Division of Urology, University of Texas Medical School at Houston, Houston, TX, USA. , Department of Urology, Skåne University Hospital, Malmö, Sweden. , Patient Advocate International Kidney Cancer Coalition (IKCC); University Medical Center Utrecht, Nephrology Department, Utrecht, The Netherlands. , Department of Urology, Sunderby Hospital, Sunderby, Sweden. , Department of Urology, Faculty Hospital and Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic. , Department of Urology and Urologic Oncology, Hannover Medical School, Hannover, Germany. , Academic Urology Unit, University of Aberdeen, Aberdeen, UK. , Department of Urology, Coimbra University Hospital, Coimbra, Portugal. , Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. , Division of Urology, Maggiore della Carità Hospital, University of Eastern Piedmont, Novara, Italy. , Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.